在儿童糖尿病方面取得的进展
1Endocrinology and Diabetes Research Unit Schneider Children's Medical Center, Tel Aviv University Medical School, Petah Tikva 49200, Israel.
Children (Basel, Switzerland)
|September 27, 2025
概括
尽管技术进步,但管理1型糖尿病 (TID) 仍然具有挑战性. 本研究探讨了新的方法来改善血糖控制和TID管理中的患者结果.
科学领域:
- 内分泌学和新陈代谢学
- 生物医学工程 生物医学工程
背景情况:
- 1型糖尿病 (TID) 是一种以胰岛素缺乏为特征的自身免疫性疾病.
- 目前TID的管理策略包括持续的葡萄糖监测和胰岛素治疗.
- 尽管取得了进展,但实现最佳的血糖控制和预防长期并发症仍然是一个重大挑战.
研究的目的:
- 评估一种新的闭环胰岛素输送系统在1型糖尿病 (TID) 管理中的有效性.
- 评估该系统对血糖控制,生活质量和患者负担的影响.
主要方法:
- 进行了一项随机对照试验,涉及1型糖尿病 (TID) 的成人患者.
- 参与者被分配到新的闭环系统或标准护理.
- 在六个月的时间里收集了持续的葡萄糖监测数据和患者报告的结果.
主要成果:
- 与标准护理组相比,闭环系统组表现出明显改善的范围 (TIR) 时间.
- 干预组的平均HbA1c水平降低了.
- 使用闭环系统的患者报告生活质量更高,糖尿病相关的痛苦减少.
结论:
- 这种新的闭环胰岛素输送系统在1型糖尿病 (TID) 管理中提供了有前途的进步.
- 这项技术可以带来更好的血糖控制和改善患者福祉.
- 进一步的研究应该探索长期成果和更广泛的实施策略.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Insulin: Dosing Regimen and Adverse Effects
685
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
685


